Joel R. Gsponer-Federer

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study.

Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study.

Journal: ESMO open

Published: March 02, 2023

Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies.

Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies.

Journal: Urologia internationalis

Published: December 18, 2020

Patterns of stemness-associated markers in the development of castration-resistant prostate cancer.

Patterns of stemness-associated markers in the development of castration-resistant prostate cancer.

Journal: The Prostate

Published: April 14, 2020

Feasibility of freehand MRI/US cognitive fusion transperineal biopsy of the prostate in local anaesthesia as in-office procedure-experience with 400 patients.

Feasibility of freehand MRI/US cognitive fusion transperineal biopsy of the prostate in local anaesthesia as in-office procedure-experience with 400 patients.

Journal: Prostate cancer and prostatic diseases

Published: October 16, 2019

Novices in MRI-targeted prostate biopsy benefit from structured reporting of MRI findings.

Novices in MRI-targeted prostate biopsy benefit from structured reporting of MRI findings.

Journal: World journal of urology

Published: July 08, 2019

Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer.

Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer.

Journal: Cancer cytopathology

Published: June 19, 2019

Structured reporting of prostate magnetic resonance imaging has the potential to improve interdisciplinary communication.

Structured reporting of prostate magnetic resonance imaging has the potential to improve interdisciplinary communication.

Journal: PloS one

Published: September 18, 2018

Building on a Solid Foundation: Enhancing Bacillus Calmette-Guérin Therapy.

Building on a Solid Foundation: Enhancing Bacillus Calmette-Guérin Therapy.

Journal: European urology focus

Published: May 15, 2018

Delineation of human prostate cancer evolution identifies chromothripsis as a polyclonal event and FKBP4 as a potential driver of castration resistance.

Delineation of human prostate cancer evolution identifies chromothripsis as a polyclonal event and FKBP4 as a potential driver of castration resistance.

Journal: The Journal of pathology

Published: October 19, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026